113722-06-8 Usage
Molecular structure
The compound has a complex molecular structure with a thiadiazine ring fused to a quinoxaline ring and is further substituted with a tetrahydro-10-methyl-1,3-diphenyl group.
Heterocyclic compound
It is a heterocyclic compound, which means it contains atoms of different elements in its ring structure.
Potential applications
The compound has potential applications in medicinal chemistry and pharmaceutical research.
Pharmacological properties
It may be investigated for its pharmacological properties, which are the actions and effects of the compound on living organisms.
Building block for synthesis
It can be used as a building block for the synthesis of novel drug candidates.
Biological activities
Its specific biological activities and potential therapeutic uses would need to be determined through further research and testing.
Molecular weight
The molecular weight of the compound is approximately 399.5 g/mol.
Appearance
The compound is likely to be a solid at room temperature, but its exact appearance (e.g., color, crystal structure) is not specified in the material provided.
Solubility
The solubility of the compound in different solvents is not specified in the material provided, but it may vary depending on the specific functional groups present in the molecule.
Check Digit Verification of cas no
The CAS Registry Mumber 113722-06-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,7,2 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 113722-06:
(8*1)+(7*1)+(6*3)+(5*7)+(4*2)+(3*2)+(2*0)+(1*6)=88
88 % 10 = 8
So 113722-06-8 is a valid CAS Registry Number.
113722-06-8Relevant articles and documents
CYCLIZATION OF N-ALKYL AZINIUM CATIONS WITH BIFUNCTIONAL NUCLEOPHILES. 21. REGIOISOMERIC 1,3,4-THIADIAZINOQUINOXALINES
Baklykov, V. G.,Charushin, V. N.,Chupakhin, O. N.,Drozd, V. N.
, p. 465 - 469 (2007/10/02)
Thiobenzhydrazides undergo cyclization with N-alkyl-quinoxalinium salts to give 5-alkyl-substituted 1,4,4a,10,10a-hexahydro-1,3,4-thiadiazinoquinoxalines, which undergo isomerization to 10-alkyl-substituted thiadiazinoquinoxalines when they are hea
